Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep;278(9):3551-3558.
doi: 10.1007/s00405-021-06726-4. Epub 2021 Mar 7.

Typical symptoms of common otorhinolaryngological diseases may mask a SARS-CoV-2 infection

Affiliations

Typical symptoms of common otorhinolaryngological diseases may mask a SARS-CoV-2 infection

Roxanne Weiss et al. Eur Arch Otorhinolaryngol. 2021 Sep.

Abstract

Purpose: Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) replicates predominantly in the upper respiratory tract and is primarily transmitted by droplets and aerosols. Taking the medical history for typical COVID-19 symptoms and PCR-based SARS-CoV-2 testing have become established as screening procedures. The aim of this work was to describe the clinical appearance of SARS-CoV-2-PCR positive patients and to determine the SARS-CoV-2 contact risk for health care workers (HCW).

Methods: The retrospective study included n = 2283 SARS-CoV-2 PCR tests from n = 1725 patients with otorhinolaryngological (ORL) diseases performed from March to November 2020 prior to inpatient treatment. In addition, demographic data and medical history were assessed.

Results: n = 13 PCR tests (0.6%) were positive for SARS-CoV-2 RNA. The positive rate showed a significant increase during the observation period (p < 0.01). None of the patients had clinical symptoms that led to a suspected diagnosis of COVID-19 before PCR testing. The patients were either asymptomatic (n = 4) or had symptoms that were interpreted as symptoms typical of the ORL disease or secondary diagnoses (n = 9).

Conclusion: The identification of SARS-CoV-2-positive patients is a considerable challenge in clinical practice. Our findings illustrate that taking a medical history alone is of limited value and cannot replace molecular SARS-CoV-2 testing, especially for patients with ORL diseases. Our data also demonstrate that there is a high probability of contact with SARS-CoV-2-positive patients in everyday clinical practice, so that the use of personal protective equipment, even in apparently "routine cases", is highly recommended.

Keywords: COVID-19; Health care workers; Medical history; Otorhinolaryngological; Pandemic; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

The authors disclose no conflict of interest.

Figures

Fig. 1
Fig. 1
Quantification of SARS-CoV-2 PCR tests (n = 2283) performed in patients (n = 1725) prior to inpatient admission from March 9 to November 30, 2020. Also shown is the number of positive SARS-CoV-2 PCR tests (n = 13 tests from n = 13 patients). A significant increase in the positive rate during the observation period was found (p < 0.01)

Similar articles

Cited by

References

    1. World Health Organisation (2020) Pneumonia of unknown cause – China. https://www.who.int/csr/don/05-january-2020-pneumonia-of-unkown-cause-ch.... Accessed 20 Jan 2021
    1. Böhmer MM, Buchholz U, Corman VM, et al. Investigation of a COVID-19 outbreak in Germany resulting from a single travel-associated primary case: a case series. Lancet Infect Dis. 2020;20:920–928. doi: 10.1016/S1473-3099(20)30314-5. - DOI - PMC - PubMed
    1. Robert-Koch-Institut (2020) Dashboard (Deutschland). https://experience.arcgis.com/experience/478220a4c454480e823b17327b2bf1d4. Accessed 20 Jan 2021
    1. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. doi: 10.1016/S0140-6736(20)30183-5. - DOI - PMC - PubMed
    1. Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77:683–690. doi: 10.1001/jamaneurol.2020.1127. - DOI - PMC - PubMed